The costs of asthma

European Respiratory Journal

Volumn 9, Issue 4, 1996, Pages 636-642

  Barnes, P J ^a   Jonsson, B ^b   Klim, J B ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Asthma; cost effectiveness; health care system; therapy

Indexed keywords

ASTHMA; COST; COST CONTROL; DISEASE CONTROL; DRUG COST; EMERGENCY WARD; HEALTH CARE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; MEDICAL FEE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIOECONOMICS;

ASTHMA; COST OF ILLNESS; COST SAVINGS; DIRECT SERVICE COSTS; DRUG COSTS; HOSPITALIZATION; HUMANS; PATIENT EDUCATION;

EID: 0029951808     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09040636     Document Type: Review

References (46)

1. Burney PGL. Epidemiology of asthma. Allergy 1993 48: 17-21.
2. National Heart Lung and Blood Institute, National Institutes of Health. International Concensus Report on diagnosis and management of asthma. 1992; Publication No. 92: 3091.
3. British Thoracic Society, British Paediatric Association, Royal College of Physicians of London, The Kings Fund Centre, The National Asthma Campaign, et al. Guidelines on the management of asthma. Thorax 1993; 48: S1-S24.
4. Scheffer AL (ed). Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. National Institute of Health, Bethesda, MD. 1995; Publication No. 95-3659.
5. Mellis CM, Peat JK, Bauman AE, Woolcock AJ. The cost of asthma in New South Wales. Med J Aust 1991; 155: 522-528.
6. National Asthma Campaign. Report on the cost of asthma in Australia. 1992.
7. Action Asthma. The occurrence and cost of asthma. Worthing, UK, Cambridge Medical Publications, 1990.
8. Teeling-Smith G. Asthma. Office of Health Economics, London. 1990.
9. Thompson S. On the social cost of asthma. Eur J Resp Dis 1984; 65: 185-191.
10. Jacobson L Lindgren B. Astma. De samhällsekonorniska kostnaderna. Studier i hälsoekonomi 8. Lund, Lund Universitet, 1995.
11. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862-866.
12. Boston Consulting Group. The costs of adult asthma in Canada. Princeton, USA, Communications Media for Education, 1993.
13. Boston Consulting Group/CRESGE. Asthme: mieux connaitre pour mieux traiter (Asthma: understand it better to treat it better). Paris, Glaxo, 1992.
14. Lenney W, Wells NEJ, O'Neill BA. The burden of paediatric asthma. Eur Respir J 1994; 4: 49-62.
15. Action Asthma. National Asthma Survey Results. Distributed by Allen and Hanburys Ltd, UK, 1991.
16. Whiteman IA, Gaduzo SC. The management of mild-to-moderate asthmatics in general practice: a retrospective analysis. B J Med Econ 1993; 6: 25-35.
17. Mawhinney H, Spector SL, Kinsman RA, et al. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy 1991; 66: 294-299.
18. Dompeling E, van Grunsven PM, van Schayck CP, Folgering H, Molema J, van Weel C. Treatment with inhaled steroids in asthma and chronic bronchitis: longterm compliance and inhaler technique. Fam Pract 1992; 9: 161-166.
19. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559-1564.
20. Bosely CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroid improve compliance? Eur Respir J 1994; 7: 504-509.
21. Blainey D, Lomas D, Beale A, Partridge M. The costs of acute asthma: how much is preventable? Health Trends 1991; 22: 151-153.
22. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-838.
23. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
24. Jones PW and the Nedocromil Sodium Quality of Life Study Group. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Eur Respir J 1994; 7: 55-62.
25. Townsend M, Feeny DH, Guyatt G, Furlong WJ, Seip AE, Dolovich J. Evaluation of the burden of illness for pediatric asthmatic patients and their parents. Ann Allergy 1991; 67: 403-408.
26. Jones PW, Pearson LMA, Stinson JC, Klim JB. The impact of asthma on an employed population (The Zeneca Asthma Study). Eur Respir J 1995; 8(Suppl. 19): 153s.
27. Fireman P, Friday GA, Gira C, Vierthaler WA, Michaels L. Teaching selfmanagement skills to asthmatic children and their parents in an ambulatory care setting. Pediatrics 1981; 68: 341-348.
28. Søndergaard B, Davidsen F, Kirkeby B, Rasmussen M, Hey H. The economics of an intensive education programme for asthmatic patients: a prospective controlled trial. Pharmacoeconomics 1992; 1: 207-212.
29. Ross RN, Morris M, Sakowitz SR, Berman BA. Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, recordbased study. Clin Ther 1988; 10: 188-203.
30. Gerdtham U-G, Hertzmann P, Boman G, Jönsson B. Impact of inhaled corticosteroids on asthma hospitalization in Sweden: a pooled regression analysis. Research Report, Ekonomiska Forskningsinstituet (EFI), Stockholm School of Economics, 1993.
31. Price DB. Patterns of prescribing inhaled steroids over a seven year period in a general practice and its implications. Thorax 1995; 50: 443 (Abstract).
32. Connett GJ, Lenney W, McConchie SM. The cost-effectiveness of budesonide in severe asthmatics aged one to three years. Br J Med Econ 1993; 6: 127-134.
33. Adelroth E, Thompson S. Advantages of high dose inhaled budesonide. Lancet 1 988; i: 476.
34. Rutten-Van Molken MPMH, van Doorslaer EKA, Jansen CC, Kertjens HAM, Rutten FFH. Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 975-982.
35. Buxton MJ, Sculpher MJ. The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formeterol versus salbutamol in asthma therapy. Pharmacoeconomics 1993; 4: 345-352.
36. Wilson S, Scamagas P, German DF, et al. A controlled trial of two forms of selfmanagement education for adults with asthma. Am J Med 1993; 94: 564-576.
37. Lewis CE, Rachelefsky G, Lewis MA, de la Sota A, Kaplan M. A randomized trial of ACT (asthma care training) for kids. Pediatrics 1984; 74: 478-486.
38. Clark NM, Feldman CH, Evans D, Levison MJ, Wasilewski Y, Mellins RB. The impact of health education on frequency and cost of health care use by low income children with asthma. J Allergy Clin Immunol 1986; 78: 108-115.
39. Bolton MB, Tilley BC, Kuder J, Reeves T, Schultz LR. The cost and effectiveness of an education program for adults who have asthma. J Gen Int Medicine 1991; 6: 401-407.
40. Muhlhauser I, Richter B, Kraut D, Weske G, Worth H, Berger M. Evaluation of a structured treatment and teaching programme on asthma. J Int Med 1991; 230: 157-164.
41. Krahn M. Issues in the cost-effectiveness of asthma education. Chest 1994; 106: 264S-269S.
42. Parcel GS, Nader PR, Tiernan K. A health education program for patients with asthma. J Dev Behav Pediatr 1980; 1: 128-132
43. Klingelhofer EL, Gershwin ME. Asthma self-management programs: premises, not promises. J Asthma 1988; 25: 89-101.
44. Charlton I, Charlton G, Broomfield J, Mullee MA. Audit of the effect of a nurse run asthma clinic on workload and patient morbidity in a general practice. Br J Gen Prac 1991; 41: 227-231.
45. Gerard K, Donaldson C, Maynard AK. The cost of diabetes. Diab Med 1989; 6: 164-170.
46. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. The economic costs of noninsulin-dependent diabetes mellitus. J Am Med Assoc 1989; 262: 2708-2713.